Daniel Kaemmerer

2.4k total citations
66 papers, 1.4k citations indexed

About

Daniel Kaemmerer is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Daniel Kaemmerer has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 49 papers in Oncology and 31 papers in Neurology. Recurrent topics in Daniel Kaemmerer's work include Neuroendocrine Tumor Research Advances (50 papers), Lung Cancer Research Studies (38 papers) and Neuroblastoma Research and Treatments (30 papers). Daniel Kaemmerer is often cited by papers focused on Neuroendocrine Tumor Research Advances (50 papers), Lung Cancer Research Studies (38 papers) and Neuroblastoma Research and Treatments (30 papers). Daniel Kaemmerer collaborates with scholars based in Germany, Austria and Italy. Daniel Kaemmerer's co-authors include Amelie Lupp, Jörg Sänger, Stefan Schulz, Merten Hommann, Richard P. Baum, Vikas Prasad, Ralph M. Wirtz, Luisa Peter, Dieter Hörsch and Harshad Kulkarni and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Annals of Surgery.

In The Last Decade

Daniel Kaemmerer

64 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel Kaemmerer 953 928 627 242 140 66 1.4k
Ruža Arsenić 483 0.5× 453 0.5× 271 0.4× 228 0.9× 221 1.6× 53 1.1k
Markus Raderer 598 0.6× 369 0.4× 328 0.5× 197 0.8× 380 2.7× 62 1.5k
Stephan U. Goebel 937 1.0× 1.1k 1.2× 740 1.2× 199 0.8× 102 0.7× 31 1.4k
G.J. Poston 798 0.8× 442 0.5× 275 0.4× 253 1.0× 226 1.6× 46 1.3k
Kjell E. Öberg 1.3k 1.4× 1.4k 1.5× 997 1.6× 146 0.6× 84 0.6× 34 2.2k
M. Manzoni 509 0.5× 389 0.4× 210 0.3× 164 0.7× 80 0.6× 38 945
Maria A. Kouvaraki 842 0.9× 770 0.8× 534 0.9× 309 1.3× 61 0.4× 23 1.7k
Monica Girotra 737 0.8× 241 0.3× 160 0.3× 251 1.0× 157 1.1× 26 1.2k
Norihiro Ishii 389 0.4× 330 0.4× 140 0.2× 193 0.8× 140 1.0× 114 1.0k
Anthony B. Daniels 225 0.2× 175 0.2× 307 0.5× 294 1.2× 180 1.3× 76 1.4k

Countries citing papers authored by Daniel Kaemmerer

Since Specialization
Citations

This map shows the geographic impact of Daniel Kaemmerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kaemmerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kaemmerer more than expected).

Fields of papers citing papers by Daniel Kaemmerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kaemmerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kaemmerer. The network helps show where Daniel Kaemmerer may publish in the future.

Co-authorship network of co-authors of Daniel Kaemmerer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kaemmerer. A scholar is included among the top collaborators of Daniel Kaemmerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kaemmerer. Daniel Kaemmerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaemmerer, Daniel & Merten Hommann. (2024). Anaphylaktischer Schock nach Misteltherapie. Die Innere Medizin. 65(11). 1147–1149.
2.
Kaemmerer, Daniel, et al.. (2024). Expression of free fatty acid receptor 2 in normal and neoplastic tissues. Experimental and Molecular Pathology. 137. 104902–104902. 1 indexed citations
3.
Kaemmerer, Daniel, et al.. (2023). Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International Journal of Molecular Sciences. 24(4). 3960–3960. 5 indexed citations
4.
Kaemmerer, Daniel, Jörg Sänger, Katja Evert, et al.. (2022). Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International Journal of Molecular Sciences. 23(9). 5191–5191. 8 indexed citations
5.
Kaemmerer, Daniel, et al.. (2022). Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data. Translational Oncology. 25. 101526–101526. 7 indexed citations
6.
Rinke, Anja, Thomas M. Gress, Jörg Schrader, et al.. (2021). Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease: A Retrospective Multicentric Study of 276 Patients. Neuroendocrinology. 112(6). 547–554. 13 indexed citations
7.
Kaemmerer, Daniel, et al.. (2019). Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International Journal of Molecular Sciences. 20(21). 5261–5261. 17 indexed citations
8.
Merola, Elettra, Anja Rinke, Stefano Partelli, et al.. (2019). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?. Annals of Surgical Oncology. 27(5). 1348–1355. 42 indexed citations
9.
Lange, Franziska, Daniel Kaemmerer, Julianne Behnke‐Mursch, et al.. (2018). Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I–IV astrocytic brain tumors. Journal of Cancer Research and Clinical Oncology. 144(7). 1227–1237. 19 indexed citations
10.
Briest, Franziska, Markus Möbs, Friederike Christen, et al.. (2017). Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors. Neuroendocrinology. 107(1). 1–23. 12 indexed citations
11.
Kaemmerer, Daniel, Uta Dahmen, A. Altendorf-Hofmann, et al.. (2017). Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets. BMC Cancer. 17(1). 896–896. 28 indexed citations
12.
13.
Kaemmerer, Daniel, Nicole Posorski, Ferdinand von Eggeling, et al.. (2014). The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm. Clinical & Experimental Metastasis. 31(7). 817–827. 16 indexed citations
14.
Hörsch, Dieter, Tillmann Bert, J. Schrader, et al.. (2012). Pancreatic neuroendocrine neoplasms.. PubMed. 58(4). 401–26. 10 indexed citations
15.
Kaemmerer, Daniel, Luisa Peter, Amelie Lupp, et al.. (2012). Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.. PubMed. 5(3). 187–94. 114 indexed citations
16.
Kaemmerer, Daniel, Brian J. Schmidt, G. Lehmann, et al.. (2012). Monthly Ibandronate for the Prevention of Bone Loss in Patients After Liver Transplantation. Transplantation Proceedings. 44(5). 1362–1367. 8 indexed citations
17.
Kaemmerer, Daniel, Vikas Prasad, Sven‐Petter Haugvik, et al.. (2012). Radioguided Surgery in Neuroendocrine Tumors Using Ga-68-Labeled Somatostatin Analogs. Clinical Nuclear Medicine. 37(2). 142–147. 21 indexed citations
18.
Kaemmerer, Daniel, et al.. (2011). Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT. Cancer Imaging. 11(1). 179–183. 6 indexed citations
19.
Kaemmerer, Daniel, Gabriele Lehmann, Günter Wolf, Utz Settmacher, & Merten Hommann. (2010). Treatment of osteoporosis after liver transplantation with ibandronate. Transplant International. 23(7). 753–759. 18 indexed citations
20.
Kaemmerer, Daniel, et al.. (2010). Reconstruction of a total avulsion of the hepatic veins and the suprahepatic inferior vena cava secondary to blunt thoracoabdominal trauma. Langenbeck s Archives of Surgery. 396(2). 261–265. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruža Arsenić Breakdown of academic impact, for papers by Markus Raderer Breakdown of academic impact, for papers by Stephan U. Goebel Breakdown of academic impact, for papers by G.J. Poston Breakdown of academic impact, for papers by Kjell E. Öberg Breakdown of academic impact, for papers by M. Manzoni Breakdown of academic impact, for papers by Maria A. Kouvaraki Breakdown of academic impact, for papers by Monica Girotra Breakdown of academic impact, for papers by Norihiro Ishii Breakdown of academic impact, for papers by Anthony B. Daniels
Rankless by CCL
2026